DexCom

NASDAQ DXCM
$127.38 0.0100 0.0079%
Today share price
USA
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 33 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

53.08B
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

54.96B
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.

0.74
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.

416.70M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.

2.64 %

Upcoming events DexCom

All events
No upcoming events scheduled

Stock chart DexCom

Stock analysis DexCom

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

83.02 53.40
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

25.66 18.68
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

64.78 38.36
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

2.23 0.81
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

28.45 18.00

Price change DexCom per year

305.63$ 579.00$
Min Max

Summary analysis DexCom

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure DexCom

Revenue and net income DexCom

All parameters

Stock news DexCom

All news

Tandem Diabetes Care Shares Rise 7% on Technology Integration With Dexcom

Tandem Diabetes Care Shares Rise 7% on Technology Integration With Dexcom

Dexcom Stock Soars on Earnings. Ozempic Isn't the Threat It Was Supposed to Be

Amazon, Intel, Ford, Enphase, Dexcom, Deckers, Exxon, Chevron, and More Stock Market Movers

Amazon, Intel, Ford, Enphase, Dexcom, Deckers, Exxon, Chevron, and More Stock Market Movers

Glucose monitor maker DexCom’s stock soars after big earnings beat, raised revenue outlook as real-time monitoring awareness grows

DexCom 3Q Profit Jumps Amid New Customer Additions

DexCom 3Q Profit Jumps Amid New Customer Additions

DexCom Stock Has Been Hit Hard By Ozempic Fears. Why They’re Overblown.

Best Buy to Sell Dexcom's Continuous Glucose Monitoring Systems

Best Buy to Sell Dexcom's Continuous Glucose Monitoring Systems

Premarket Movers: Healthcare Realty Trust, DexCom, Tesla

DexCom Shares Up 4% After FDA Approval of Continuous Glucose Monitoring System

DexCom Shares Up 4% After FDA Approval of Continuous Glucose Monitoring System

Glucose monitoring device maker DexCom stock rallies more than 50% in October to pace the S&P 500

Dexcom Stock Soars on Earnings and Revenue Beat

Dexcom Stock Soars on Earnings and Revenue Beat

DexCom Shares Jump 9.6% on Adjusted 2022 Outlook, 3Q Rev Above Estimates

DexCom Shares Jump 9.6% on Adjusted 2022 Outlook, 3Q Rev Above Estimates

DexCom Shares Up 9.4% After CMS Proposal That Could Benefit Its Products

About company DexCom

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company offers its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom G7, a next generation G7 CGM system; and Dexcom Share, a remote monitoring system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop next-generation CGM products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.
Address:
6340 Sequence Drive, San Diego, CA, United States, 92121
Company name: DexCom
Issuer ticker: DXCM
ISIN: US2521311074
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2005-04-14
Sector: Healthcare
Industry: Health Care Equipment & Supplies
Site: https://www.dexcom.com

On which stock exchange are DexCom (DXCM) stocks traded?

DexCom (DXCM) stocks are traded on NASDAQ.

What is the ticker of DexCom stocks (DXCM)?

The stock ticker of DexCom’s stocks or in other words, the code is DXCM. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does DexCom (DXCM) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, DexCom (DXCM) belongs to the «Healthcare» sector and the «Health Care Equipment & Supplies» industry.

In what currency are DexCom (DXCM) stocks traded?

DexCom (DXCM) stocks are traded on the NASDAQ exchange in dollars.

What is the price of DexCom (DXCM) stocks today?

The current price of DexCom stocks on 29.05.2024 is 127.38 dollars. per share.

What is the dynamics of DexCom (DXCM) stocks from the beginning of the year?

DexCom (DXCM) quotes have increased by 3.49% from the beginning of the year up to 127.38 dollars. per 1 stocks.

How much did DexCom (DXCM) stocks increase in may 2024?

This month DexCom (DXCM) quotes have increased by 1.19% to 127.38 dollars. per share.

How much are DexCom (DXCM) stocks worth?

Today, on October, 29.05.2024 DexCom’s (DXCM) stocks cost 127.38 dollars..

What is the market capitalization of DexCom (DXCM)?

Capitalization is the market value of DexCom (DXCM) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 29.05.2024, the market capitalization of DexCom (DXCM) is estimated at about 53075079000 dollars.